GR1006552B - Ενδοπροστατικο ελατηριο-δοκιδα-βελονα/εγχυση/ενεσιμη μεθοδος - Google Patents

Ενδοπροστατικο ελατηριο-δοκιδα-βελονα/εγχυση/ενεσιμη μεθοδος

Info

Publication number
GR1006552B
GR1006552B GR20080100303A GR20080100303A GR1006552B GR 1006552 B GR1006552 B GR 1006552B GR 20080100303 A GR20080100303 A GR 20080100303A GR 20080100303 A GR20080100303 A GR 20080100303A GR 1006552 B GR1006552 B GR 1006552B
Authority
GR
Greece
Prior art keywords
tissues
rapamycin
stent
lymph
prostate
Prior art date
Application number
GR20080100303A
Other languages
English (en)
Inventor
Νικολαος Χρηστου Δημοφιλος
Original Assignee
Νικολαος Χρηστου Δημοφιλος
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Νικολαος Χρηστου Δημοφιλος filed Critical Νικολαος Χρηστου Δημοφιλος
Priority to GR20080100303A priority Critical patent/GR1006552B/el
Priority to PCT/GR2009/000027 priority patent/WO2009130518A1/en
Publication of GR1006552B publication Critical patent/GR1006552B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/08—Coatings comprising two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Με το δεσμευμένο αυτούσιο υπό νέα χρήση Cypher, (Cordis company), όπως και με τις καινοτόμες προσθήκες [ΝΕΕΣ] δυναμικών κατασκευαστικών μηχανικών μορφών φαρμακευτικών κλπ. καινούργιων, ή, υπό άλλο πρίσμα ιδωμένων παραμέτρων, (πχ SHIGA-Stx StxA toxinκλπ.) το όλο σύστημα, θα χρησιμοποιηθεί ανάλογα των εμπλεκομένων καταστάσεων, για παρεμπόδιση ανάπτυξης υπερπλαστικών ιστών, [λείων εν γένει] καλοήθους βάσης, η καρκινικών, λόγω των ιδιοτήτων της ραπαμυκίνης, να επιδρά ακριβώς εκεί, όπως και στα λεμφοκύτταρα [λεμφικός ιστός]. Ο νάρθηκας, δίκην σωληνωτού ελατηρίου, (stent) θα παρέξει εγνωσμένες μηχανικές ιδιότητες, εμπλουτισμένο δε με την τοξίνη, θα προκαλέσει περαιτέρω ανοσοδιέγερση. Δέσμευση επίσης και της προτεινόμενης απεικονιστικής δυνατότητας της ραπαμυκίνης για στοχευμένη αγκίστρωση και κακείθεν απεικόνιση του ογκικού δυναμικού-περιβάλλοντος αλλά και φαρμακευτική ομοίως δράση, [μεταφορέας φαρμάκων] σε λεμφικούς ιστούς εν γένει καθώς επίσης και της εννοιολογικής μεθοδολογικής επισήμανσης όλων των χρήσεων της, υπό οιανδήποτε μορφή [αυτούσιας, συνδεδεμένης, ως επίστρωση κλπ.] σε ουρολογικά πεδία, [αναφερόμενα στο κείμενο όπως νεφρό, προστάτης, όρχης, συναφείς λεμφαδένες, ουρητήρες. . . ], όπως και σε λεμφικούς ιστούς, εν γένει (υγρούς - συμπαγείς) χορηγούμενη σε υγρή μορφή από του στόματος, ή κατευθείαν στον όγκο, μόνη ή συνδεμένη, όπως στο κείμενο άπλετα αναφέρουμε. . . .
GR20080100303A 2008-04-24 2008-04-24 Ενδοπροστατικο ελατηριο-δοκιδα-βελονα/εγχυση/ενεσιμη μεθοδος GR1006552B (el)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GR20080100303A GR1006552B (el) 2008-04-24 2008-04-24 Ενδοπροστατικο ελατηριο-δοκιδα-βελονα/εγχυση/ενεσιμη μεθοδος
PCT/GR2009/000027 WO2009130518A1 (en) 2008-04-24 2009-04-23 Intraprostatic stent coil-bar-pin infusion /injection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20080100303A GR1006552B (el) 2008-04-24 2008-04-24 Ενδοπροστατικο ελατηριο-δοκιδα-βελονα/εγχυση/ενεσιμη μεθοδος

Publications (1)

Publication Number Publication Date
GR1006552B true GR1006552B (el) 2009-10-02

Family

ID=40791267

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20080100303A GR1006552B (el) 2008-04-24 2008-04-24 Ενδοπροστατικο ελατηριο-δοκιδα-βελονα/εγχυση/ενεσιμη μεθοδος

Country Status (2)

Country Link
GR (1) GR1006552B (el)
WO (1) WO2009130518A1 (el)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014DN10834A (el) * 2001-09-17 2015-09-04 Psivida Inc
US20050255230A1 (en) * 2004-05-17 2005-11-17 Clerc Claude O Method of manufacturing a covered stent
WO2006036982A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Drug delivery coating for use with a stent
EP1858438B1 (en) * 2005-03-15 2019-03-06 SurModics, Inc. Compliant polymeric coatings for insertable medical articles
US20070162110A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Bioabsorbable drug delivery devices

Also Published As

Publication number Publication date
WO2009130518A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
TR201809231T4 (tr) Hiyalüronidaz ve bir tümör-güdümlü taksan ile kombinasyon terapisi.
CA2819240C (en) Aptamer bioconjugate drug delivery device
CL2009001014A1 (es) Composicion de insulina de accion superrapida que comprende insulina y una enzima de degradacion de hialuronano; sistema de lazo cerrado que comprende la composicion; metodo para preparar la composicion; uso de la composicion.
MX2010006991A (es) Tratamientos de cancer terapeuticos.
WO2012018404A3 (en) Use of her3 binding agents in prostate treatment
MX2013007316A (es) Cojugados de suministro de polinucleotidos in vivo que tienen acoplamientos sensibles a enzima.
MX2011003557A (es) Vendas para heridas con capa de interfaz.
ATE489048T1 (de) Vorrichtung für kombinierte behandlung
NZ591719A (en) Balloon catheter medical device coated with therapeutic agent and povidone-iodine
PH12014500213A1 (en) Poly (acrylate) polymers for in vivo nucleic acid delivery
WO2009127882A3 (en) A mobile wireless device with an embedded media player
HRP20180660T1 (hr) Sustavi i postupci za liječenje tkiva prostate
WO2009123824A3 (en) Stent with nucleating agent
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
EP4218718A3 (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
WO2011103146A3 (en) A post foaming gel composition comprising an anti-irritation agent
EP2596425A4 (en) Membership tracking and data eviction in mobile middleware scenarios
WO2007128973A3 (en) Interleukin 1-receptor antagonist composition to treat restenosis
ATE528013T1 (de) Impfstoff-zusammensetzungen
WO2011088178A3 (en) Personal care composition comprising a hydrophobically modified cationic polysaccharide
WO2008090585A3 (en) Soluble forms of inclusion complexes of histone deacetylase inhibitors and cyclodextrins, their preparation processes and uses in the pharmaceutical field
IL200517A0 (en) Agent for use in the case of fructose intolerance
BR112013006004A2 (pt) celulose nano-desagregada
BR112012025196A2 (pt) prognóstico com base genética da reincidência do antígeno prostático específico (psa) para pacientes com câncer de próstata clinicamente localizado
WO2011006908A3 (en) Metal complexes having dual histone deacetylase inhibitory and dna-binding activity

Legal Events

Date Code Title Description
PG Patent granted